Sinocare Asks Court To Rule Device Won't Infringe Abbott IP

By Hanna Vioque ( September 23, 2026, 4:35 PM BST) -- Chinese medical device maker Sinocare has asked a London judge for a declaration that a modified version of its iCan glucose monitoring device doesn't infringe two Abbott patents, in the midst of a court battle between the rivals set for trial in 2027....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login